Abstract
Cohesin complex components are frequently mutated in human myeloid cancers. Three new studies now show that cohesin mutations disrupt the differentiation of normal hematopoietic stem and progenitor cells and enhance self-renewal, shedding light on how these alterations may contribute to leukemic transformation.
Original language | English |
---|---|
Journal | Cell Stem Cell |
Volume | 17 |
Issue number | 6 |
DOIs | |
Publication status | Published - 3 Dec 2015 |
Research Beacons, Institutes and Platforms
- Manchester Cancer Research Centre